---
title: "PacBio director Christopher Smith resigns from board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292240396.md"
description: "Pacific Biosciences of California Inc. announced that director Christopher M. Smith resigned from the board, effective July 8, 2026. The company stated there were no disagreements with its operations, policies, or practices regarding his departure."
datetime: "2026-07-09T20:34:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292240396.md)
  - [en](https://longbridge.com/en/news/292240396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292240396.md)
---

# PacBio director Christopher Smith resigns from board

-   Pacific Biosciences disclosed the resignation of director Christopher M. Smith, effective immediately on July 8, 2026. \* No disagreements with the company’s operations, policies, or practices were cited in connection with the departure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001299130-26-000111), on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PACB.US](https://longbridge.com/en/quote/PACB.US.md)

## Related News & Research

- [PacBio to join Canaccord Genuity Growth Conference fireside chat](https://longbridge.com/en/news/294107597.md)
- [PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News](https://longbridge.com/en/news/283506957.md)
- [PacBio expects $165M-$175M 2026 revenue as SPRQ-Nx ships later this month](https://longbridge.com/en/news/285683555.md)
- [Barclays Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.00](https://longbridge.com/en/news/282748678.md)
- [Pacific Biosciences of California Q1 Earnings Call Highlights](https://longbridge.com/en/news/285721292.md)